SCHEMBL20182235

SCHEMBL20182235

CCC(/C(=C/Nc1cc(F)ccc1F)N=N)n1cc(-c2cc(F)cnc2OC)c2c(N)ncnc21

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EIF2AK3 Q9NZJ5 3/20 0.34
NTRK1 P04629 2/20 0.32
NTRK3 Q16288 1/20 0.32
NTRK2 Q16620 1/20 0.32
EGFR P00533 4/20 0.32
ABL1 P00519 2/20 0.32
ABL2 P42684 2/20 0.32
AXL P30530 1/20 0.31
TEK Q02763 3/20 0.31
SRC P12931 2/20 0.31
ERBB2 P04626 1/20 0.31
ERBB3 P21860 1/20 0.31
ERBB4 Q15303 1/20 0.31
KDR P35968 3/20 0.31
PIK3CD O00329 1/20 0.31
PIK3CA P42336 1/20 0.31
PIK3CB P42338 1/20 0.31
PIK3CG P48736 1/20 0.31
PRKDC P78527 1/20 0.31
KCNH2 Q12809 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20182289 0.94 NTRK1 (0.36) EIF2AK3NTRK1NTRK3NTRK2EGFR
SCHEMBL20182194 0.94 EIF2AK3 (0.36) EIF2AK3EGFRABL1ABL2TEK
SCHEMBL20182222 0.91 AXL (0.34) EIF2AK3EGFRABL1ABL2AXL
SCHEMBL20182265 0.86 NTRK1 (0.36) EIF2AK3NTRK1NTRK3NTRK2EGFR
SCHEMBL20182292 0.86 NEK7 (0.37) EIF2AK3NTRK1NTRK3NTRK2EGFR
SCHEMBL20181910 0.85 CFTR (0.38) EIF2AK3NTRK1NTRK3NTRK2SRC
SCHEMBL20181916 0.84 CFTR (0.39) EIF2AK3EGFRABL1ABL2TEK
SCHEMBL20182275 0.83 EGFR (0.36) EIF2AK3EGFRABL1ABL2AXL
SCHEMBL20182271 0.82 CFTR (0.35) EIF2AK3EGFRABL1ABL2AXL
SCHEMBL20182191 0.82 ALK (0.34) EIF2AK3EGFRABL1ABL2AXL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018094137-A1 PYRROLOPYRIMIDINES AS CFTR POTENTIATORS CYSTIC FIBROSIS FOUNDATION THERAPEUTICS INC. (US) 2018-05-24 WO disclosed